Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUKfour: Vorinostat, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01720875Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Aug 2013
- Primary completion
- Aug 2015
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in multiple myeloma (MM), sponsored by University of Leeds. Started Aug 2013; status: completed.
02
Drugs
vorinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01720875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720875.